Nuformix (LON:NFX) Stock Price Up 12.7% – What’s Next?

Nuformix plc (LON:NFX)’s share price was up 12.7% on Wednesday . The company traded as high as GBX 0.19 and last traded at GBX 0.19. Approximately 7,078,999 shares changed hands during trading, a decline of 81% from the average daily volume of 38,177,867 shares. The stock had previously closed at GBX 0.17.

Nuformix Price Performance

The company has a market cap of £4.62 million, a P/E ratio of -4.50 and a beta of 1.55. The stock’s 50-day moving average is GBX 0.20 and its two-hundred day moving average is GBX 0.25.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.